PDLIM5 and breast carcinoma: In 2018, one study on the epigenetic regulation of LIM family genes in different breast cancer subtypes confirmed that the putative promoter region of LIMD1 and our predicted gene LPP may be abnormally methylated in the MDA-MB435 cell line [53].